EditorialEditorial
Possible Consequences of a Shortage of Hydroxychloroquine for Patients with Systemic Lupus Erythematosus amid the COVID-19 Pandemic
Christine A. Peschken
The Journal of Rheumatology April 2020, jrheum.200395; DOI: https://doi.org/10.3899/jrheum.200395
Christine A. Peschken
University of Manitoba Arthritis Centre, Rady Faculty of Health Sciences, Winnipeg, Manitoba, Canada. Address correspondence to Dr. C.A. Peschken, University of Manitoba, RR149 Arthritis Centre, 800 Sherbrook St., Winnipeg, Manitoba R3A 1M4, Canada. E-mail: christine.peschken@umanitoba.ca
In this issue
The Journal of Rheumatology
Vol. 51, Issue 4
1 Apr 2024
Possible Consequences of a Shortage of Hydroxychloroquine for Patients with Systemic Lupus Erythematosus amid the COVID-19 Pandemic
Christine A. Peschken
The Journal of Rheumatology Apr 2020, jrheum.200395; DOI: 10.3899/jrheum.200395